Ameriprise’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.1M | Sell |
76,197
-1,076
| -1% | -$254K | ﹤0.01% | 1402 |
|
|
2026
Q1 | $15.4M | Sell |
77,273
-20,991
| -21% | -$4.15M | ﹤0.01% | 1591 |
|
|
2025
Q4 | $18.6M | Sell |
98,264
-2,979
| -3% | -$572K | ﹤0.01% | 1468 |
|
|
2025
Q3 | $17.9M | Sell |
101,243
-8,450
| -8% | -$1.26M | ﹤0.01% | 1480 |
|
|
2025
Q2 | $12.5M | Sell |
109,693
-17,338
| -14% | -$1.85M | ﹤0.01% | 1654 |
|
|
2025
Q1 | $13.4M | Buy |
127,031
+31,327
| +33% | +$3.54M | ﹤0.01% | 1562 |
|
|
2024
Q4 | $10.3M | Buy |
95,704
+1,759
| +2% | +$199K | ﹤0.01% | 1783 |
|
|
2024
Q3 | $9.4M | Sell |
93,945
-6,096
| -6% | -$614K | ﹤0.01% | 1847 |
|
|
2024
Q2 | $8.43M | Sell |
100,041
-16,252
| -14% | -$1.29M | ﹤0.01% | 1902 |
|
|
2024
Q1 | $8.5M | Buy |
116,293
+9,718
| +9% | +$716K | ﹤0.01% | 1932 |
|
|
2023
Q4 | $7.61M | Sell |
106,575
-28,868
| -21% | -$1.7M | ﹤0.01% | 2016 |
|
|
2023
Q3 | $8.12M | Sell |
135,443
-10,651
| -7% | -$701K | ﹤0.01% | 1870 |
|
|
2023
Q2 | $10.5M | Buy |
146,094
+13,566
| +10% | +$1.02M | ﹤0.01% | 1733 |
|
|
2023
Q1 | $9.75M | Sell |
132,528
-2,549
| -2% | -$181K | ﹤0.01% | 1797 |
|
|
2022
Q4 | $9.02M | Sell |
135,077
-95,776
| -41% | -$6.23M | ﹤0.01% | 1822 |
|
|
2022
Q3 | $12.4M | Sell |
230,853
-9,809
| -4% | -$577K | ﹤0.01% | 1498 |
|
|
2022
Q2 | $13.4M | Buy |
240,662
+62,171
| +35% | +$3.53M | ﹤0.01% | 1503 |
|
|
2022
Q1 | $12.5M | Sell |
178,491
-1,125
| -0.6% | -$81.6K | ﹤0.01% | 1721 |
|
|
2021
Q4 | $17.3M | Buy |
179,616
+2,122
| +1% | +$196K | ﹤0.01% | 1534 |
|
|
2021
Q3 | $15.4M | Buy |
177,494
+31,403
| +21% | +$2.43M | ﹤0.01% | 1483 |
|
|
2021
Q2 | $12M | Sell |
146,091
-1,638
| -1% | -$136K | ﹤0.01% | 1790 |
|
|
2021
Q1 | $14.1M | Sell |
147,729
-121,846
| -45% | -$11.5M | ﹤0.01% | 1594 |
|
|
2020
Q4 | $16.7M | Sell |
269,575
-61,210
| -19% | -$3.49M | 0.01% | 1357 |
|
|
2020
Q3 | $19.7M | Sell |
330,785
-401,186
| -55% | -$27.4M | 0.01% | 1082 |
|
|
2020
Q2 | $51.1M | Buy |
731,971
+200,799
| +38% | +$12.7M | 0.02% | 620 |
|
|
2020
Q1 | $24.1M | Buy |
531,172
+37,393
| +8% | +$2.12M | 0.01% | 840 |
|
|
2019
Q4 | $32.1M | Sell |
493,779
-38,372
| -7% | -$2.56M | 0.01% | 904 |
|
|
2019
Q3 | $33M | Buy |
532,151
+31,465
| +6% | +$1.98M | 0.01% | 847 |
|
|
2019
Q2 | $35.6M | Sell |
500,686
-29,330
| -6% | -$2.16M | 0.02% | 836 |
|
|
2019
Q1 | $41.6M | Sell |
530,016
-569,639
| -52% | -$43.2M | 0.02% | 737 |
|
|
2018
Q4 | $93.1M | Buy |
1,099,655
+66,823
| +6% | +$7.12M | 0.05% | 396 |
|
|
2018
Q3 | $177M | Sell |
1,032,832
-193,734
| -16% | -$29.2M | 0.06% | 307 |
|
|
2018
Q2 | $159M | Sell |
1,226,566
-11,742
| -0.9% | -$1.31M | 0.07% | 282 |
|
|
2018
Q1 | $128M | Buy |
1,238,308
+585,291
| +90% | +$57.9M | 0.06% | 317 |
|
|
2017
Q4 | $55.8M | Buy |
653,017
+37,595
| +6% | +$3.26M | 0.03% | 547 |
|
|
2017
Q3 | $52.3M | Buy |
615,422
+47,481
| +8% | +$3.76M | 0.02% | 555 |
|
|
2017
Q2 | $43M | Sell |
567,941
-4,122
| -0.7% | -$288K | 0.02% | 612 |
|
|
2017
Q1 | $37.8M | Sell |
572,063
-97,936
| -15% | -$6.44M | 0.02% | 656 |
|
|
2016
Q4 | $42.5M | Sell |
669,999
-21,663
| -3% | -$1.37M | 0.02% | 589 |
|
|
2016
Q3 | $44M | Buy |
691,662
+39,675
| +6% | +$2.91M | 0.02% | 550 |
|
|
2016
Q2 | $48.4M | Buy |
651,987
+27,896
| +4% | +$2.07M | 0.03% | 489 |
|
|
2016
Q1 | $41.7M | Buy |
624,091
+104,743
| +20% | +$6.37M | 0.02% | 545 |
|
|
2015
Q4 | $35.1M | Buy |
519,348
+4,359
| +0.8% | +$269K | 0.02% | 614 |
|
|
2015
Q3 | $27.5M | Sell |
514,989
-42,727
| -8% | -$2.59M | 0.02% | 735 |
|
|
2015
Q2 | $35.1M | Buy |
557,716
+24,779
| +5% | +$1.35M | 0.02% | 668 |
|
|
2015
Q1 | $25.6M | Buy |
532,937
+328,227
| +160% | +$12.6M | 0.01% | 847 |
|
|
2014
Q4 | $6.8M | Buy |
204,710
+6,481
| +3% | +$211K | ﹤0.01% | 1841 |
|
|
2014
Q3 | $5.81M | Sell |
198,229
-36,575
| -16% | -$1.21M | ﹤0.01% | 1930 |
|
|
2014
Q2 | $9.12M | Buy |
234,804
+46,274
| +25% | +$1.88M | 0.01% | 1617 |
|
|
2014
Q1 | $7.91M | Buy |
188,530
+26,992
| +17% | +$1.13M | ﹤0.01% | 1707 |
|
|
2013
Q4 | $5.3M | Buy |
161,538
+123,137
| +321% | +$4.01M | ﹤0.01% | 1962 |
|
|
2013
Q3 | $1.04M | Sell |
38,401
-48,599
| -56% | -$1.37M | ﹤0.01% | 2674 |
|
|
2013
Q2 | $2.03M | Buy |
+87,000
| New | +$1.56M | ﹤0.01% | 2356 |
|
Other funds holding LGND
JT
CAM
Ameriprise's LGND Position: Q2 2026 in Review
Ameriprise reduced its Ligand Pharmaceuticals (LGND) stake by 1.4% in Q2 2026, selling an estimated $254K and leaving 76,197 shares worth $24.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1402.
Ameriprise first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $177M in Q3 2018. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Ameriprise held 76,197 shares of Ligand Pharmaceuticals worth $24.1M as of Q2 2026.
- Ameriprise sold 1,076 Ligand Pharmaceuticals shares in Q2 2026, an estimated $254K.
- Ligand Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1402 holding.
- Ameriprise first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Ameriprise's Ligand Pharmaceuticals position peaked at $177M in Q3 2018.
- 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.